Why $CAPR is setting up for a massive gain tomorrow (FDA BLA + 15.5M Short Shares Trapped)

AI SUMMARY — Capriotti's (CAPR) has FDA BLA approval coming tomorrow with 15.5M short shares trapped, creating potential for a significant short squeeze and stock price surge. Key risks include regulatory delays, FDA rejection, and the possibility that short sellers exit positions before the catalyst rather than getting squeezed.